Uncategorized

No deal between AstraZeneca and BMS, senior source insists: Reuters

Published

on

Reuters has deflated rumors that AstraZeneca and Bristol Myers Squibb are discussing a possible merger, letting the air out of industry-wide speculation over what could have been the largest deal in pharma history.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version